GRAMD4P7: A Promising Drug Target / Biomarker (G100631251)

Target Name: GRAMD4P7

NCBI ID: G100631251

GRAMD4P7

Other Name(s): GRAM domain containing 4 pseudogene 7

GRAMD4P7: A Promising Drug Target / Biomarker

Grammar cells are a type of protein that play a crucial role in the structure and function of cells. They are responsible for the formation of the cell's cytoskeleton, which provides support and structure for the cell's various organelles. One of the well-known proteins that belong to the Grammar family is GRAMD4P7, which is a protein that is expressed in various tissues of the body. In this article, we will discuss the potential significance of GRAMD4P7 as a drug target or biomarker.

Structure and Function

GRAMD4P7 is a member of the Grammar family, which includes several proteins that are involved in the formation of the cell's cytoskeleton. These proteins are characterized by the presence of a unique transmembrane domain and a cytoplasmic tail. The transmembrane domain is responsible for the protein's ability to interact with other proteins and molecules that are located on the cell's surface. The cytoplasmic tail is responsible for the protein's ability to localize to specific cellular locations within the cytoplasm.

GRAMD4P7 is a 21-kDa protein that is expressed in various tissues of the body, including muscle, heart, brain, and liver. It is involved in the formation of the cell's cytoskeleton, which is a complex network of filaments and fibers that provide support and structure for the cell's various organelles. The cytoskeleton is composed of several different proteins, including microtubules, actin filaments, and intermediate filaments. These proteins work together to help the cell maintain its shape and move in response to external stimuli.

GRAMD4P7 is involved in the formation of the cytoskeleton by helping to regulate the activity of several different proteins. One of the key functions of GRAMD4P7 is its role in the regulation of the cytoskeleton's stability. This is accomplished through the interaction of GRAMD4P7 with several different proteins, including microtubules and actin filaments. By interacting with these proteins, GRAMD4P7 helps to regulate the cytoskeleton's stability and ensures that it remains in the correct shape and position.

Another important function of GRAMD4P7 is its role in the regulation of cell signaling pathways. This is accomplished through the interaction of GRAMD4P7 with several different signaling proteins. For example, GRAMD4P7 has been shown to interact with the protein kinase A-Tyr, which is involved in the regulation of many different cellular processes. By interacting with A-Tyr, GRAMD4P7 helps to regulate the activity of this protein and ensure that it functions correctly.

GRAMD4P7 is also involved in the regulation of the cytoskeleton's flexibility. This is accomplished through the interaction of GRAMD4P7 with several different proteins that help to regulate the cytoskeleton's shape and stability. For example, GRAMD4P7 has been shown to interact with the protein F-actinin, which is involved in the regulation of the cytoskeleton's flexibility. By interacting with F-actinin, GRAMD4P7 helps to regulate the activity of this protein and ensure that the cytoskeleton remains in the correct shape and position.

Drug Targeting

GRAMD4P7 has several potential drug targeting opportunities. One of the main targets for GRAMD4P7 is the regulation of the cytoskeleton's stability. This is accomplished through the regulation of microtubules and actin filaments, which are involved in the

Protein Name: GRAM Domain Containing 4 Pseudogene 7

The "GRAMD4P7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GRAMD4P7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets